Article
A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis.
Disease markers - 1 Jan 2016
Han Yali, Liu Jie, Sun Meili, Zhang Zongpu, Liu Chuanyong, Sun Yuping
Abstract excerpt
BACKGROUND: There is no definitive conclusion so far on the predictive values of ERCC1 polymorphisms for clinical outcomes of platinum-based chemotherapy in non-small cell lung cancer (NSCLC). We updated this meta-analysis with an expectation to obtain some statistical advancement on this issue. METHODS: Relevant studies were identified by searching MEDLINE, EMBASE databases from inception to April 2015. Primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.